AUSTRALIAN medical cannabis sales tanked by over a quarter in the second half of 2025, following a clampdown on the previous ‘profit before patient’ model A report from the Penington Institute shows that medical cannabis sales peaked in the second half of 2024 at 3.72m units before falling to 2.65m units in the second half…
Cannabis drugmakers prepare for IPOs, nearly 400 operators rush to register with the DEA, microdosing data reframes consumer use patterns, and regulators from Israel to the Bahamas reshape their frameworks as Schedule III aftershocks ripple worldwide.
Reclassification confusion, an IPO revival in cannabis pharma and a contentious DEA registration form dominate today’s cannabis news, alongside fresh European consolidation and a return of investor focus on the sector’s ETFs.
Reform momentum builds on both sides of the Atlantic as Richard Branson presses for UK cannabis change, Indiana’s governor signals openness to legalisation, and analysts map the banking access unlocked by US rescheduling.
Today’s cannabis briefing covers the fallout from the US Justice Department’s Schedule III order, fresh travel guidance for UK medical patients, California’s ten-year legalisation milestone, environmental scrutiny at a Trulieve mega-grow, and a notable state-level legalisation recommendation in North Carolina.
As New Yorkers prepare to head to the polls to vote for their new Mayor tomorrow (Tuesday, November 04), the state’s vast but unsettled cannabis market has become a key battleground for the three hopefuls.
VIRGINIA CANNABIS Virginia House panel kills GOP-led push to legalize retail cannabis sales Benzinga reports that Virginia lawmakers struck down a push to legalize and set a framework for retail sales of recreational cannabis on Tuesday.
NEW YORK LAWSUIT Judge rejects New York challenge to suit that’s delaying cannabis store openings MJ Biz Daily reports that a federal judge rejected New York’s effort to toss a lawsuit that’s been delaying the opening of recreational cannabis stores across the state, including in Brooklyn – continuing the wait for the issuance of 63…
INSPIRE TECHNOLOGY Three firms steer e-cig and cannabis firm’s $42m IPO filing Law 360 reports that the e-cigarette and cannabis vaping product brand Ispire Technology plans to raise up to USD$42 million by offering six million shares at a price range of $6 to $8 each.
